NCT03650361 - Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris | Biotech Hunter

Enrollment

755

Participants

Timeline

Start Date

September 17, 2018

Primary Completion Date

February 16, 2019

Study Completion Date

February 16, 2019

Conditions

Acne Vulgaris

Interventions

DRUG

Adapalene Gel 0.3%

Treatment applied as a thin layer of the product to the entire face once a day in the evening for 84 days

DRUG

Differin 0.3% Topical Gel

Treatment applied as a thin layer of the product to the entire face once a day in the evening for 84 days

DRUG

Adapalene Gel 0.3% Vehicle Placebo

Treatment applied as a thin layer of the product to the entire face once a day in the evening for 84 days

Trial Locations (10)

Dermatology Consulting Services, PLLC, High Point

FXM Research Miramar, Miramar

FXM Research Corp., Miami

Moore Clinical Research Institute, Inc., Brandon

Moore Clinical Research Institute, Inc., Tampa

Moore Clinical Research Institute, Inc., Tampa

3A Research, LLC, El Paso

3A Research, LLC, El Paso

Unison Center for Clinical Trials, Sherman Oaks

FXM Research International, Belize City